CLINICAL_TRIALS
research
· 2025-04-03
Clinical Trial Update: MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation [NA]
Summary
This ClinicalTrials.gov entry reports the MARINER trial evaluating multiparametric cardiac PET to surveil cardiac allograft vasculopathy in heart transplant rec…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Cardiac Allograft Vasculopathy | NA | Status: RECRUITING